Back to Trades
Hallett David
Chief Scientific OfficerCIK 0002006495
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 4
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Hallett David, Chief Scientific Officer, has filed 4 SEC reports (2026), all concentrated in RECURSION PHARMACEUTICALS, INC. (RXRX), totaling $252.2K in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| Aug 18 | RXRX RECURSION PHARMACEUTICALS, INC. | Hallett David | Chief Scientific Officer | Tax withheld | $84.2K |
| May 19 | RXRX RECURSION PHARMACEUTICALS, INC. | Hallett David | Chief Scientific Officer | Tax withheld | $81.0K |
| Feb 19 | RXRX RECURSION PHARMACEUTICALS, INC. | Hallett David | Chief Scientific Officer | Tax withheld | $41.6K |
| Feb 10 | RXRX RECURSION PHARMACEUTICALS, INC. | Hallett David | Chief Scientific Officer | Grant | $45.4K |
4 filings